期刊文献+

国内干细胞治疗环境及临床应用现状 被引量:2

Stem Cell Therapy Environment and Clinical Application in China
下载PDF
导出
摘要 干细胞作为一种具有不同分化潜能的细胞,其为解决现代医学难题带来了曙光.近年来,国内众多医疗机构和学者开展了干细胞对各类疾病的临床应用研究,并在多种疾病如肿瘤、糖尿病、心脑血管疾病的治疗上取得了一定的成果.本文就国内当前关于干细胞治疗领域的制度环境及临床应用现状进行了分析与阐述. As a cell with diversified differentiation potentials,the stem cell has brought the dawn to the solution to the hard nut of modern medicine.In recent years,many domestic medical institutions and scholars have conducted clinical research and application of stem cell therapy,with certain achievements in the treatment of many diseases such as tumors,diabetes,and cardiovascular and cerebrovascular diseases.This paper analyzes and expounds the current institutional environment and clinical application of stem cell therapy in China.
作者 张沁瑶 叶鑫健 过金晶 潘清 ZHANG Qinyao;YE Xinjian;GUO Jinjing;PAN Qing(School of Stomatology,Zhejiang Chinese Medical University,Hangzhou,Zhejiang 310053;Shaoxing Lanbei Investment Management Co.Ltd.,Shaoxing,Zhejiang 312000)
出处 《绍兴文理学院学报》 2021年第8期115-119,共5页 Journal of Shaoxing University
基金 浙江省大学生科技创新活动计划暨新苗人才计划项目“基于Rhino软件的一种口腔颌面外科术后紫草敷贴联合冷敷理疗方案”(2020R410016).
关键词 干细胞 干细胞治疗 制度环境 临床应用 stem cell stem cell therapy institutional environment clinical application
  • 相关文献

参考文献5

二级参考文献31

  • 1郑学宝,李大平.国外医疗技术准入制度比较[J].中国医院管理,2006,26(4):15-17. 被引量:13
  • 2李大平.探索性医疗技术临床准入立法的基本原则和基本制度[J].法律与医学杂志,2007,14(2):89-101. 被引量:14
  • 3Azuaki Yoshikawa.Cell cycle regulators in neural stem cells and postmitotic neurons[].Neurosciences Research.
  • 4Dufayet de la Tour D,Halvorsen T,Demeterco C,et al.b-cell differentiation from a human pancreatic cell line in vitro and in vivo[].Molecular Endocrinology.
  • 5Domen J. and Weissman I L.Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate[].Mol Med Today.
  • 6Thomson J A,Itskovitz-Eldor J,Shapiro S S et al.Embryonic stem cell lines derived from human blastocysts[].Science.
  • 7Jones J M,Thomson J A.Human embryonic stem cell technology[].Semin Reprod Med.
  • 8Nichols J,Zevnik B,Anastassiadis K,et al.Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4[].Cell.
  • 9Shamblott M J,Axelman J,Wang S,et al.Derivation of pluripotent stem cells from cultured human primordial germ cells[].Proceedings of the National Academy of Sciences of the United States of America.
  • 10Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies[J]. New England journal of medicine, 2006, 355(16): 1730-1735.

共引文献27

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部